George Simeon
George Simeon is a board director and former Chairman and CEO of Curevo Vaccine, where he led the company from formation through clinical development, raised over $200 million in venture financing, and oversaw its acquisition by Eli Lilly. He previously founded HealthLink Global and served as CEO at Black Kactus LLC. His executive leadership roles have included positions at Johnson & Johnson, Novartis, SK Telecom, GHX Europe, and Forth Photonics Ltd.
-
Curevo Executive Officer, Director 2022, Former Chairman & Chief Executive Officer 2019 · past -
Black Kactus LLC CEO 2018–2020 · past
-
SK Telecom Healthcare Strategy Team 2014–2018 · past
-
HealthLink Global Founder 2012–2018 · past
-
GHX Europe Vice-President - Multinational Supplier Business Unit 2011–2012 · past
-
GS1 Senior Advisor 2006–2010 · past
-
Forth Photonics Ltd CEO 2003 · past
-
Johnson & Johnson European Vice-President Cordis Neurovascular 2000–2002, Director Cordis Endovascular Division (France) 1999–2000, Director Reimbursement and Government Relations (Cordis) 1997–1999 · past
-
Novartis Manager Economic Evaluation 1994–1997 · past
Education
-
Università Bocconi Master of Philosophy - MPhil, Strategy & Technology Management · 2004–2007
-
INSEAD MBA · 1998–1999
-
Yale School of Public Health Master of Public Health - MPH, Epidemiology, Health Economics · 1992–1994
-
University of Ottawa B.Soc.Sc, Economics · 1988–1992